Szerző: " Gecse Krisztina Barbara"

Gönczi Lóránt; Kürti Zsuzsanna; Rutka Mariann; Végh Zsuzsanna; Farkas Klaudia; Lovász Barbara Dorottya; Golovics Petra Anna; Gecse Krisztina Barbara; Szalay Balázs; Molnár Tamás; Lakatos Péter László: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.
BMC GASTROENTEROLOGY, 17 (1). Azonosító: 97.-Terjedelem: 7 p.. ISSN 1471-230X (2017)

Bálint Anita; Rutka Mariann; Végh Zsuzsanna; Kürti Zsuzsanna; Gecse Krisztina Barbara; Lakatos László; Szepes Zoltán; Vincze Áron; Bor Renáta; Milassin Ágnes; Fábián Anna; Nagy Ferenc; Lakatos Péter László; Molnár Tamás; Farkas Klaudia: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
EXPERT OPINION ON DRUG SAFETY, 16 (8). pp. 885-890. ISSN 1474-0338 (2017)

Gönczi Lóránt; Gecse Krisztina Barbara; Végh Zsuzsanna; Kürti Zsuzsanna; Rutka Mariann; Farkas Klaudia; Golovics Petra Anna; Lovász Barbara Dorottya; Banai János; Bene László; Gasztonyi Beáta; Kristóf Tünde; Lakatos László; Miheller Pál; Nagy Ferenc: Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort.
INFLAMMATORY BOWEL DISEASES, 23 (11). pp. 1908-1915. ISSN 1078-0998 (2017)

Gönczi Lóránt; Végh Zsuzsanna; Golovics Petra Anna; Rutka Mariann; Gecse Krisztina Barbara; Bor Renáta; Farkas Klaudia; Szamosi Tamás; Bene László; Gasztonyi Beáta; Kristóf Tünde; Lakatos László; Miheller Pál; Palatka Károly; Papp Mária: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
JOURNAL OF CROHNS & COLITIS, 11 (6). pp. 697-705. ISSN 1873-9946 (2017)

Gecse Krisztina Barbara; Lovász Barbara Dorottya; Farkas Klaudia; Banai János; Bene László; Gasztonyi Beáta; Golovics Petra Anna; Csontos Ágnes Anna; Juhász Márk; Nagy Ferenc; Papp Mária; Szepes Zoltán; Vincze Áron; Szalay Balázs; Molnár Tamás; Lakatos Péter László: Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective; multicentre; nationwide cohort.
JOURNAL OF CROHNS & COLITIS, 10 (2). pp. 133-140. ISSN 1873-9946 (2016)

Farkas Klaudia; Rutka Mariann; Golovics Petra Anna; Végh Zsuzsanna; Lovász Barbara Dorottya; Nyári Tibor András; Gecse Krisztina Barbara; Kolar Martin; Bortlik Martin; Duricovad Dana; Machkova Nadezda; Hruba Veronika; Bálint Anita; Nagy Ferenc; Bor Renáta; Milassin Ágnes; Szepes Zoltán; Palatka Károly; Lakatos Péter László; Lukasd Milan; Molnár Tamás: Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis.
JOURNAL OF CROHNS & COLITIS, 10 (11). pp. 1273-1278. ISSN 1873-9946 (2016)

Kürti Zsuzsanna; Lovász Barbara Dorottya; Gecse Krisztina Barbara; Bálint Anita; Farkas Klaudia; Morocza-Szabó Ágnes; Gyurcsányi András; Kristóf Attila; Végh Zsuzsanna; Gönczi Lóránt; Kiss Lajos Sándor; Golovics Petra Anna; Lakatos László; Molnár Tamás; Lakatos Péter László: Tuberculin skin test and Quantiferon in BCG vaccinated; immunosuppressed patients with moderate-to-severe inflammatory bowel disease.
Journal of Gastrointestinal and Liver Diseases, 24 (4). pp. 467-472. ISSN 1841-8724 (2015)